Lack Of Energy and Diaformin


Lack Of Energy Symptoms and Causes

Chronic fatigue syndrome (CFS) is a disorder that causes extreme fatigue. This fatigue is not the kind of tired feeling that goes away after you rest. Instead, it lasts a long time and limits your ability to do ordinary daily activities.

The main symptom of CFS is severe fatigue that lasts for 6 months or more. You also have at least four of these other symptoms:

  • Feeling unwell for more than 24 hours after physical activity
  • Muscle pain
  • Memory problems
  • Headaches
  • Pain in multiple joints
  • Sleep problems
  • Sore throat
  • Tender lymph nodes

CFS is hard to diagnose. There are no tests for it, and other illnesses can cause similar symptoms. Your doctor has to rule out other diseases before making a diagnosis of CFS.

No one knows what causes CFS. It is most common in women in their 40s and 50s, but anyone can have it. It can last for years. There is no cure for CFS, so the goal of treatment is to improve symptoms. CFS affects people in different ways. You should work with your doctors to create a treatment program that best meets your own needs. It may include therapies to manage your symptoms, such as medicines to treat pain, sleep disorders, and other problems. It may also include coping techniques, and ways of managing your daily activities.

Centers for Disease Control and Prevention

Check out the latest treatments for Lack Of Energy

Lack Of Energy treatment research studies

Diaformin clinical trials, surveys and public health registries

Find Drug Side Effect reports

Diaformin Side Effects

Fatigue (56)
Arterial Disorder (40)
Hunger (36)
Dyspnoea (36)
Blood Glucose Increased (31)
Angioneurotic Oedema (20)
Weight Decreased (18)
Renal Failure Acute (14)
Dehydration (13)
Vomiting (11)
Pernicious Anaemia (8)
Hypoglycaemia (6)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

<b>i feel sick all the time im on diaformin 850</b>

Been overdosed over nine months on 5700mg of Diaformin per dayby my GP. Had lost weight, loss of appetite anaemia B12 deficiency vitamin D deficiency lethagy pains in back on exertion etc. Rushed to hospital, no recordable blood sugar, acut

Dosage 3x500mg daily. Nausea, loss of appetite, Possibly also constipation.On Thyroxine,Tritace,Cardizem,Natrilix,Lipitor,Cartia. Because of the nausea myDiet therefore not well balanced any more which affects

Had to increase dosage to 1000mg twice a day. Immediately began to find it difficult to summon any energy to do any normal day to day acttivities eg washing, cooking. Diarhoea, lethargy, increase in thirst ( nothing quen

I am a type 2 diabetic 62 years of age, female,and recently my doctor has increased my Diafomin 1000g from two a day to three times a day...she has also stated me on a new Blood Presssure tablet called Avapro HCT 300/25 since I started them I have

I am diaform 500mg 3 times a day each time two tablets I have running stomach and I am very tired and very stress My diabetic is type 2


I first started with diaformin early August, I now have very bad diarohhea which has now strated for the last 4 days as a very dark green that flows like water. This happins after each meal.

I have been on diaformin for 3 months, I have type 2 diabettes and have an ongoing heart condition. Iam 51, i have noticed excessive sweating and feeling hot continually, also fatigue and the runs. i am on 3 tablets of 500mgs per day. my sugar leve

I have diabetes type 2 and I use 3 or 4 diaformin 500mg tablets daily and I have had great results with them - my blood sugar was about 17 plus after a light meal before using them and now is very slightly above 7 or max 9 after food intake.

Iama 41year old whitefemale After taking OTC delsym for a cough I developed pain in my back left side and severe fatigue, no energy. Thinking at first the illness just

<strong>Does Calcium Chloride contain energy</strong>?

59 years old .perscribed diovan for high blood presure.after 2 monthes i have mustle pain,joint pain,waight gain,bloting of midsection,no energy,no sex drivecant sleep because i cough half the night headachs,and just feel generly lousy.blood presure

A lot of the symptoms people are displaying are typical symptoms from stopping smoking and lack of nicotine. These symptoms cannot be directly attributed to 'Champix'. I have 'tried' stopping several times using various methods i.e. cold turkey, patc

About 40 min - an hour after taking Crestor I wake feeling shaky almost like I've had 5 or 6 cups of coffee. My muscles feel like they are &quot;vibrating&quot; for lack of a better word. Needless to say after the 3rd dose I had to stop takin

Acute lower back pain causing lack of mobility?

Afater taking glifage for 5 months, stopped because of complete lack of appetite and taste, loss of 20 lbs. and thinking process affected.

After being very stressed over money worries,and manic through lack of sleep,was prescribed zopiclone,was extremely confused,and my short term memory was severely affected.put myself in danger by driving and not reallky knowing where was,even though

After dealing with nausea for days, total lack of appetite I then started with a temp.of 101.5 and it went up to 103. That lasted for 3 days ( my sinuss infection at this point was cleard up, so I stopped taking the meds. NOW, I am experiencing very

After having stilnoct for atleast 6 months, there is occuring of head heaviness,fever, dry mouth,constipation, lack of appetite.

Lack Of Energy Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
Conditions: Obesity;   Metabolic Syndrome;   Schizophrenia
Interventions: Drug: Metformin;   Drug: placebo
Outcome Measures: body weight change;   metabolic features
2 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication and Abnormal Glucose Metabolism
Conditions: Peripheral Arterial Disease;   Intermittent Claudication;   Glucose Metabolism Disorders
Interventions: Drug: Metformin;   Drug: Placebo
Outcome Measures: Change in pain-free walking time;   Change in maximum walking time;   Change in questionnaire-based markers of quality of life / perceived functional capacity;   Change in endothelial function;   Change in skeletal muscle blood flow response to insulin;   Change in skeletal muscle blood flow response to acute exercise;   Change in insulin sensitivity;   Change in objectively measured physical activity / sedentary behaviour in the daily life setting.
3 Recruiting A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 15 mg;   Drug: Placebo to Ertugliflozin;   Other: Glimepiride;   Drug: Placebo to Glimepiride;   Biological: Basal Insulin;   Drug: Metformin
Outcome Measures: Change from Baseline in Hemoglobin A1c;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose;   Change from Baseline in Body Weight at Week 26;   Number of participants with a HbA1c of <7% (53 mmol/mol) at Week 26;   Change from Baseline in Systolic Blood Pressure;   Change from Baseline in Diastolic Blood Pressure;   Change from Baseline in Bone Mineral Density at Week 26;   Change from Baseline in Bone Mineral Density at Week 52;   Change from Baseline in Bone Mineral Density at Week 104;   Number of participants with HbA1c <=6.5% (48 mmol/mol) at Week 26;   Number of participants requiring glycemic rescue therapy up to Week 26;   Time to glycemic rescue therapy up to Week 26;   Change from baseline in bone biomarkers at Week 26;   Change from baseline in bone biomarkers at Week 52;   Change from baseline in bone biomarkers at Week 104
4 Recruiting A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin (5 mg);   Drug: Ertugliflozin (10 mg);   Drug: Placebo to Ertuglifozin;   Drug: Metformin;   Drug: Placebo to Metformin
Outcome Measures: Change from Baseline In Hemoglobin A1c (HbA1c) at Week 26;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose (FPG) at Week 26;   Change from Baseline in Body Weight at Week 26;   Number of Participants with a HbA1c <7% (53 mmol/mol) at Week 26;   Change from Baseline in 2-hour Post-prandial Plasma Glucose at Week 26;   Change from Baseline in Systolic Blood Pressure at Week 26;   Change from Baseline in Diastolic Blood Pressure at Week 26